• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

AI and Machine Learning

The latest news on AI and machine learning in pharma — from drug discovery and clinical trials to commercial strategy and FDA-backed innovation.

digital twins
CRO

Boehringer, Microsoft explore digital twins for clinical trials

The program will initially focus on lung health, with plans to explore its potential across additional diseases and therapeutic areas.
Marissa Russo Oct 26, 2026 2:49pm
digital dollar with tech background

Anthropic details drug R&D ambitions, risks in IPO filing

Oct 26, 2026 2:00pm
Pathos AI CEO Iker Huerga

BMS leads Pathos' $237M series E alongside Alzheimer's link-up

Oct 23, 2026 8:00am
Astellas

Astellas links up with AI Proteins in $400M drug discovery deal

Oct 21, 2026 9:14am
Oracle booth sign at HIMSS24 conference

AstraZeneca taps Oracle to improve recruitment for trials

Oct 20, 2026 2:36am
Eli Lilly booth at AACR 2026

Lilly allies with Metis in $1.1B AI nanoparticle discovery deal

Oct 19, 2026 10:45am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings